Recent reports of child deaths in Madhya Pradesh and Rajasthan, allegedly linked to contaminated cough syrups, have prompted the Gujarat government to initiate a comprehensive probe. This action highlights widespread concerns regarding
cough syrup contamination
and patient safety across India. The investigation aims to determine if cough syrups sold within Gujarat contain any harmful ingredients, ensuring public health remains protected.
Gujarat Health Minister Rushikesh Patel informed reporters in Gandhinagar that companies under scrutiny following child fatalities are not on the buyer list of Gujarat Medical Services Corporation Ltd (GMSCL), the state-owned medicine procurement entity. This statement offers initial reassurance; nevertheless, precautionary measures are being actively implemented.
Rising Concerns Over Cough Syrup Contamination
Tragically, children have lost their lives in both Rajasthan and Madhya Pradesh after consuming specific cough syrups. Reports indicate that dextromethorphan-based cough syrups and Coldrif syrup were implicated in these deaths. Specifically, in Madhya Pradesh, nine children died in Chhindwara district since September 7 due to suspected kidney infection. Subsequently, the MP government banned the sale of Coldrif syrup, manufactured in Kanchipuram, Tamil Nadu, and extended the ban to other products from the same company. Tests later confirmed the presence of highly toxic diethylene glycol (DEG) in samples of Coldrif syrup. Similarly, Rajasthan reported child deaths allegedly due to contaminated cough syrup. The state government halted the supply of all 19 medicines from Jaipur-based Kaysons Pharma and suspended distribution of other cough syrups containing dextromethorphan.
Considering these grave reports, Gujarat’s state health and family welfare department investigated if GMSCL had procured these specific cough syrups. It was confirmed that none of the implicated companies were on their buyer list. Despite this, a statewide probe has been ordered to ascertain whether such harmful ingredients are present in any cough syrups currently available in Gujarat.
Nationwide Response to Cough Syrup Contamination
The Central Drugs Standard Control Organisation (CDSCO) has also initiated risk-based inspections at manufacturing units of 19 drugs, including cough syrups and antibiotics, across six states. These inspections aim to identify quality control lapses and recommend improvements to prevent future incidents. The Director General of Health Services (DGHS) also issued an advisory to all States and Union Territories regarding the rational use of cough syrups in the paediatric population. States like Tamil Nadu and Kerala have also banned Coldrif syrup as a precautionary measure. Authorities are now taking strict action, including arrests of individuals involved and booking pharmaceutical companies responsible for the manufacturing of substandard drugs. These coordinated efforts highlight a critical focus on ensuring drug safety and preventing future tragedies.
Frequently Asked Questions
Q1: What prompted the Gujarat government’s probe into cough syrups?
The Gujarat government ordered a probe following reports of child deaths in Madhya Pradesh and Rajasthan allegedly linked to contaminated cough syrups containing harmful ingredients like dextromethorphan and diethylene glycol.
Q2: Which cough syrups were implicated in the child deaths?
Coldrif syrup (manufactured by Sresan Pharmaceuticals, Tamil Nadu) was linked to deaths in Madhya Pradesh, while dextromethorphan-based cough syrups (including those from Kaysons Pharma, Jaipur) were implicated in Rajasthan.
Q3: Has the Gujarat Medical Services Corporation Ltd (GMSCL) procured these implicated syrups?
No, Gujarat Health Minister Rushikesh Patel confirmed that the companies under scanner are not on the buyer list of the state-owned medicine procurement entity, GMSCL.
References
- Gujarat govt orders probe to check presence of harmful ingredients in coughsyrups – ETHealthworld
- No contaminants found in cough syrup samples linked to child deaths; DGHS issues advisory on paediatric use – DD News
- India probes possible cough syrup link to deaths of at least nine children – Al Jazeera
- MP bans Coldrif cough syrup sale following death of 14 children; toxic chemical found in samples – The Economic Times
- Now, 12 kids’ deaths linked to cough syrup in MP, Raj; Centre issues advisory | India News
- Madhya Pradesh Bans Coldrif Cough Syrup Following Children’s Deaths from Kidney Failure – Newsonair
- 11 children deaths in MP: Doctor who prescribed ‘poisoned’ cough syrup arrested; Tamil Nadu-based firm booked | Bhopal News – The Times of India
- Madhya Pradesh bans cough syrup linked to deaths of 9 children – The Hindu
- Cough syrup deaths: Manufacturer Kaysons Pharma under lens – India Today
- Rajasthan cough syrup row: 11 child deaths trigger suspension of drug controller, Kaysons Pharma drugs pulled from market – The Economic Times
- Coldrif row: Why are states banning the cough syrup | Explained – Hindustan Times
- Doctor arrested after 11 children die in Madhya Pradesh from toxic cough syrup
- Firm Behind Cough Syrup Linked To Child Deaths Under Scanner In Rajasthan – NDTV
- Drug watchdog wants action against Coldrif makers under serious offences: Report
Disclaimer: This article was automatically generated from publicly available sources and is provided for informational and educational purposes only. OC Academy does not exercise editorial control or claim authorship over this content. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider and refer to current local and national clinical guidelines.